These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20012407)

  • 21. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
    Williams DR
    Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anatamopathological spectrum of tauopathies.
    Revesz T; Holton JL
    Mov Disord; 2003 Sep; 18 Suppl 6():S13-20. PubMed ID: 14502651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proteins and mutations: a new vision (molecular) of neurodegenerative diseases].
    Christen Y
    J Soc Biol; 2002; 196(1):85-94. PubMed ID: 12134639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice.
    Lomoio S; Scherini E; Necchi D
    Brain Res; 2009 Nov; 1297():198-206. PubMed ID: 19703431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
    Sorrentino G; Bonavita V
    Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
    Zilka N; Korenova M; Novak M
    Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.
    Schindowski K; Belarbi K; Bretteville A; Ando K; Buée L
    Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):92-100. PubMed ID: 18184373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key?
    Walker LC; Bian F; Callahan MJ; Lipinski WJ; Durham RA; LeVine H
    Amino Acids; 2002; 23(1-3):87-93. PubMed ID: 12373522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A decade of modeling Alzheimer's disease in transgenic mice.
    McGowan E; Eriksen J; Hutton M
    Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice.
    Pennanen L; Welzl H; D'Adamo P; Nitsch RM; Götz J
    Neurobiol Dis; 2004 Apr; 15(3):500-9. PubMed ID: 15056457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
    Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic mouse models of neurodegenerative diseases.
    Trancikova A; Ramonet D; Moore DJ
    Prog Mol Biol Transl Sci; 2011; 100():419-82. PubMed ID: 21377633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic zebrafish models of neurodegenerative diseases.
    Sager JJ; Bai Q; Burton EA
    Brain Struct Funct; 2010 Mar; 214(2-3):285-302. PubMed ID: 20162303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral phenotyping of mouse models of neurodegeneration.
    Dumont M
    Methods Mol Biol; 2011; 793():229-37. PubMed ID: 21913104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy.
    Casarejos MJ; Perucho J; Gomez A; Muñoz MP; Fernandez-Estevez M; Sagredo O; Fernandez Ruiz J; Guzman M; de Yebenes JG; Mena MA
    J Alzheimers Dis; 2013; 35(3):525-39. PubMed ID: 23478312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease: old problem, new views from transgenic and viral models.
    Jaworski T; Dewachter I; Seymour CM; Borghgraef P; Devijver H; Kügler S; Van Leuven F
    Biochim Biophys Acta; 2010 Oct; 1802(10):808-18. PubMed ID: 20332023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogen free conditions slow the onset of neurodegeneration in a mouse model of nerve growth factor deprivation.
    Capsoni S; Carucci NM; Cattaneo A
    J Alzheimers Dis; 2012; 31(1):1-6. PubMed ID: 22504318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse models as a tool for understanding neurodegenerative diseases.
    Ahmad-Annuar A; Tabrizi SJ; Fisher EM
    Curr Opin Neurol; 2003 Aug; 16(4):451-8. PubMed ID: 12869802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.